Single Dose, Weight-Based, Dose-Escalation Study With Intravenous ETI-204 in Adult Volunteers
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This study will determine the safety and PK of a single IV dose of ETI-204 in subjects 18 to
65 years of age. Three cohorts will be studied with subjects receiving ETI-204. This study
will be randomized, double-blind and stratified by gender. Each cohort will contain 36
subjects (including at least four females), 30 who will receive ETI-204 and six who will
receive placebo.